CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
86 hedge funds and large institutions have $1.48B invested in China Biologic Products Holdings, Inc. in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
-7
Holders Change %
-7.53%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
30
Reduced
26
Closed
17
Calls
$2.42M
Puts
$7.32M
Net Calls
-$4.89M
Net Calls Change
+$824K
Top Buyers
| 1 |
VAM
Vontobel Asset Management
New York
|
+$64.3M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$56.3M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$43.2M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$41.5M |
| 5 |
BlackRock
New York
|
+$20.1M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$75.9M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$45.3M |
| 3 |
ICP
Indus Capital Partners
New York
|
-$26M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$22.9M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$22.5M |
